Key result
The Prostate Cancer Education & Resources for Couples (PERC) eHealth intervention is currently being evaluated in a randomized controlled trial to assess its efficacy on quality of life, with no results reported in this protocol.
Why the study?
Managing the negative effects of localized prostate cancer and its treatment on couples' relationships, intimacy, and quality of life is a significantly under-addressed supportive care need.
Does a couple-focused, tailored eHealth intervention (PERC) improve cancer-related quality of life in men with localized prostate cancer and their partners?
RCT (n=500)
Single-blind
Permuted block randomization with variable block size
No
Does a couple-focused, tailored eHealth intervention (PERC) improve cancer-related quality of life in men with localized prostate cancer and their partners?
Answers are grounded in this paper and cite their sources.
This study protocol outlines a randomized controlled trial to evaluate a tailored eHealth intervention for improving quality of life in men with localized prostate cancer and their partners.
BACKGROUND: Men with localized prostate cancer often experience urinary, sexual, bowel, and hormonal symptoms; general distress; pain; fatigue; and sleep disturbance. For men in an intimate relationship, these symptoms disrupt couples' relationships and intimacy. The symptoms also reduce quality of life for both men and their partners, who are often their primary caregivers. Management of the negative effects of cancer and its treatment is a significantly under-addressed supportive care need for these men and their intimate partners. To address these unmet supportive care needs, our interdisciplinary team developed and pilot tested the usability and feasibility of an evidence-based, couple-focused, tailored eHealth intervention, "Prostate Cancer Education & Resources for Couples" (PERC). Based on the adapted stress and coping theoretical framework and developed with stakeholder involvement, PERC aims to improve quality of life for both men and their partners by enhancing their positive appraisals, self-efficacy, social support, and healthy behaviors for symptom management. METHODS: We will test the efficacy of PERC using a population-based, geographically and demographically diverse cohort in a randomized controlled trial. Primary aim: Assess if patients and partners receiving PERC will report greater improvement in their cancer-related quality of life scores than those in the control group (usual care plus the National Cancer Institute prostate cancer website) at 4, 8, and 12 months post-baseline. Secondary aim: Test if patients and partners in PERC will report significantly more positive appraisals and higher levels of coping resources at follow-ups than those in the control group. Exploratory aim: Determine if patient race and ethnicity, education, type of treatment, or couples' relationship quality moderate the effects of PERC on patient and partner QOL at follow-ups. DISCUSSION: This study will provide a novel model for self-managing chronic illness symptoms that impact couples' relationships, intimacy, and quality of life. It addresses the National Institute of Nursing Research's goal to develop and test new strategies for symptom self-management to help patients and caregivers better manage their illness and improve quality of life. It also responds to calls for programs from the Institute of Medicine and American Cancer Society to address treatment-related effects and improve survivors' QOL. TRIAL REGISTRATION: CT.gov NCT03489057.
No takes yet. Share an insight, caveat, or question.
Song et al. (2022) conducted an RCT in Localized prostate cancer (n=500). Prostate Cancer Education & Resources for Couples (PERC) eHealth intervention vs. Usual care plus the National Cancer Institute (NCI) prostate cancer website was evaluated on Cancer-related quality of life (QOL) scores measured by FACT-G at 4, 8, and 12 months post-baseline. The Prostate Cancer Education & Resources for Couples (PERC) eHealth intervention is currently being evaluated in a randomized controlled trial to assess its efficacy on quality of life, with no results reported in this protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: